Great-West Lifeco Inc (TSE:GWO) Director Michel Plessis-Bélair bought 5,000 shares of the business’s stock in a transaction dated Tuesday, March 24th. The shares were bought at an average price of C$21.72 per share, with a total value of C$108,576.00. Following the completion of the transaction, the director now owns 55,000 shares in the company, valued at approximately C$1,194,336.

Michel Plessis-Bélair also recently made the following trade(s):

  • On Friday, March 20th, Michel Plessis-Bélair bought 10,000 shares of Great-West Lifeco stock. The shares were bought at an average price of C$23.71 per share, with a total value of C$237,100.00.

Great-West Lifeco stock opened at C$23.61 on Thursday. The company has a debt-to-equity ratio of 27.24, a quick ratio of 10.90 and a current ratio of 13.24. Great-West Lifeco Inc has a 52 week low of C$18.88 and a 52 week high of C$35.60. The stock has a market capitalization of $20.44 billion and a P/E ratio of 9.47. The stock has a fifty day moving average of C$30.23 and a 200-day moving average of C$31.91.

Great-West Lifeco (TSE:GWO) last posted its quarterly earnings results on Wednesday, February 12th. The company reported C$0.80 EPS for the quarter, topping analysts’ consensus estimates of C$0.79 by C$0.01. The business had revenue of C$10.69 billion for the quarter. On average, research analysts forecast that Great-West Lifeco Inc will post 3.3900001 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 31st will be issued a $0.438 dividend. This represents a $1.75 dividend on an annualized basis and a yield of 7.42%. The ex-dividend date of this dividend is Monday, March 2nd. This is a boost from Great-West Lifeco’s previous quarterly dividend of $0.41. Great-West Lifeco’s dividend payout ratio is presently 66.27%.

A number of analysts have recently weighed in on the company. CIBC upped their target price on Great-West Lifeco from C$34.00 to C$36.00 in a research report on Friday, February 14th. CSFB set a C$37.00 price target on Great-West Lifeco and gave the stock a “neutral” rating in a report on Friday, February 7th. National Bank Financial lowered their price target on Great-West Lifeco from C$33.00 to C$31.00 in a report on Monday, March 9th. Credit Suisse Group reissued a “neutral” rating and set a C$37.00 price target on shares of Great-West Lifeco in a report on Friday, February 7th. Finally, BMO Capital Markets boosted their price target on Great-West Lifeco from C$34.00 to C$35.00 in a report on Friday, February 14th. One research analyst has rated the stock with a sell rating, six have given a hold rating and one has given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of C$33.60.

Great-West Lifeco Company Profile

Great-West Lifeco Inc, a financial services holding company, engages in life and health insurance, asset management, investment and retirement savings, and reinsurance businesses in Canada, the United States, and Europe. The company offers a portfolio of financial and benefit plan solutions for individuals, families, businesses, and organizations; life, disability, critical illness, accidental death, dismemberment, dental protection, direct marketing, health, and creditor insurance products; and wealth savings and income, accumulation, and annuity products.

Read More: What is the Fibonacci sequence?

Receive News & Ratings for Great-West Lifeco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Great-West Lifeco and related companies with MarketBeat.com's FREE daily email newsletter.